Target intelligence / Profile preview

Proteasome subunit beta type-9 (PSMB9)

Target
PSMB9
Molecular classification
Enzyme, Threonine protease, Proteasome subunit
01

Overview

Proteasome subunit beta type-9 (PSMB9), also known as LMP2 or proteasome beta-1i subunit, is a catalytic subunit of the immunoproteasome, a specialized form of the 20S proteasome core. It is constitutively expressed in hematopoietic cells and can be induced in non-hematopoietic cells by inflammatory cytokines, particularly interferon-gamma (IFN-gamma). PSMB9 replaces the constitutive beta-1c subunit (PSMB6) to alter the cleavage specificity of the proteasome, favoring the generation of hydrophobic and basic peptides that are optimal for loading onto major histocompatibility complex (MHC) class I molecules. This process is essential for antigen processing and presentation, enabling CD8+ T-cell-mediated immune surveillance against viral infections and malignant cells.

In pathological contexts, PSMB9 is implicated in autoimmune diseases, chronic inflammation, and various cancers. Overexpression of PSMB9 is observed in inflammatory conditions like rheumatoid arthritis and lupus nephritis, where it drives aberrant immune activation and cytokine production. Conversely, in oncology, PSMB9 expression is associated with tumor-immune infiltration and serves as a prognostic biomarker for response to immune checkpoint inhibitors and CAR-T cell therapies. Therapeutic targeting of PSMB9 involves both pan-proteasome inhibitors (such as bortezomib and carfilzomib) and selective immunoproteasome inhibitors (such as zetomipzomib/KZR-616 and experimental agents like KZR-504 or ML604440). Inhibiting PSMB9 disrupts immunoproteasome function, dampening autoimmune responses and inflammatory cytokine release, making it a highly promising target for autoimmune and inflammatory disorders.

Other names
Proteasome subunit beta-1iLow molecular mass protein 2LMP2PSMB6iRING12Really interesting new gene 12 proteinMacropain chain 7Multicatalytic endopeptidase complex chain 7Proteasome chain 7Proteasome 20S subunit beta 9
02

Mechanism of action

Inhibition of the threonine-type endopeptidase activity of the immunoproteasome, preventing the degradation of intracellular proteins into peptides for MHC class I antigen presentation, thereby modulating immune responses and cytokine production.

03

Biological functions

Antigen processing and presentationProtein degradationImmune responseApoptosisCell cycle regulation
04

Disease associations

Autoimmune diseaseInflammationCancerNeurodegenerative diseaseRheumatoid arthritisSystemic lupus erythematosusLupus nephritisColorectal cancerAlzheimer's disease
05

Safety considerations

Systemic toxicityImmunosuppressionImpaired antigen presentationIncreased susceptibility to viral infectionsDefects in B and T helper cell function
06

Interacting drugs

8 more in the full profile.

07

Biomarkers

PSMB9 expression levelLMP2 expression levelInterferon-gamma levelsCD8+ T-cell infiltration

Beyond the preview

Go deeper on Proteasome subunit beta type-9 (PSMB9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proteasome subunit beta type-9 (PSMB9).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call